Lexington Hill Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Sell
550
-16
-3% -$16.3K 0.32% 36
2026
Q1
$521K Buy
566
+149
+36% +$151K 0.3% 42
2025
Q4
$448K Buy
+417
New +$399K 0.34% 42

Other funds holding LLY

Lexington Hill Partners's LLY Position: Q2 2026 in Review

Lexington Hill Partners reduced its Eli Lilly (LLY) stake by 2.8% in Q2 2026, selling an estimated $16.3K and leaving 550 shares worth $660K. The position accounts for 0.32% of the portfolio, ranked #36.

Lexington Hill Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lexington Hill Partners held 550 shares of Eli Lilly worth $660K as of Q2 2026.
  • Lexington Hill Partners sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.32% of Lexington Hill Partners's portfolio in Q2 2026, its #36 holding.
  • Lexington Hill Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lexington Hill Partners's 13F filing for Q2 2026, filed 8 Jul 2026.